Greenlight Capital’s Medicines Co MDCO Stock Holding History

Greenlight Capital’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-229,900	Closed	-$19.5M	–	30
2019 Q4	$19.5M	Sell	229,900 -501,700	-69%	-$33.5M	1.45%	14
2019 Q3	$36.6M	Hold	731,600	–	–	2.63%	10
2019 Q2	$26.7M	Sell	731,600 -217,200	-23%	-$7.09M	1.97%	13
2019 Q1	$26.5M	Hold	948,800	–	–	1.88%	13
2018 Q4	$18.2M	Hold	948,800	–	–	1.31%	16
2018 Q3	$28.4M	Sell	948,800 -51,200	-5%	-$1.93M	1.2%	15
2018 Q2	$36.7M	Hold	1,000,000	–	–	1.17%	16
2018 Q1	$32.9M	Hold	1,000,000	–	–	0.83%	22
2017 Q4	$27.3M	Buy	+1,000,000	New	+$30.8M	0.5%	25

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Greenlight Capital's MDCO Position: Q1 2020 in Review

Greenlight Capital sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 229,900 shares — an estimated $19.5M sold.

Greenlight Capital first reported a position in MDCO in Q4 2017 and held it in 9 quarters. The position peaked at $36.7M in Q2 2018. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Greenlight Capital reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Greenlight Capital sold 229,900 Medicines Co shares in Q1 2020, an estimated $19.5M.
Greenlight Capital first reported a position in Medicines Co in Q4 2017 and held it in 9 quarters.
Greenlight Capital's Medicines Co position peaked at $36.7M in Q2 2018.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Greenlight Capital's 13F filing for Q1 2020, filed 15 May 2020.